Menu Search
Equities

Bruker Corp

BKD:BER

Bruker Corp

Actions
  • Price (EUR)68.50
  • Today's Change-1.50 / -2.14%
  • Shares traded0.00
  • 1 Year change+14.17%
  • Beta--
Data delayed at least 15 minutes, as of Jun 09 2023 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy & Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. The BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, and others. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research.

  • Revenue in USD (TTM)2.62bn
  • Net income in USD311.50m
  • Incorporated2000
  • Employees8.53k
  • Location
    Bruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
  • Phone+1 (978) 663-3660
  • Fax+1 (978) 663-5585
  • Websitehttps://www.bruker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BRKR:NSQ since
announced		Transaction
value
OSTHUS Beteiligungs GmbHDeal completed04 May 202304 May 2023Deal completed-7.70%30.30m
ACQUIFER Imaging GmbHDeal completed05 Jan 202305 Jan 2023Deal completed5.50%--
Biognosys AGDeal completed04 Jan 202304 Jan 2023Deal completed7.21%--
Neurescence IncDeal completed12 Nov 202212 Nov 2022Deal completed5.92%--
Inscopix IncDeal completed08 Nov 202208 Nov 2022Deal completed11.72%--
Data delayed at least 15 minutes, as of Jun 08 2023 21:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.